MME advises Karl Storz on Ankiln acquisition
Zurich-based MME advised German MedTech company Karl Storz on its acquisition of Anklin.
The context
Karl Storz is a family-owned global company, active in the endoscopy and medical instruments sectors. Founded in 1954 and now at its third generation, this German reality employs 9.400 employees across 40 different countries, managing production sites all across the US, Switzerland, Estonia, and its homeland Germany. Their catalogue features 13.000 products for both human and veterinary medicine.
Reinach-based Anklin is active in the distribution a distributor of high-precision medical instruments and devices in the field of endoscopy for human and veterinary medicine, serving the entire Swiss market in all language regions and employing a dedicated team of around 70 specialists.
The collaboration between the two goes way back in history. Still today, the vast majority of Anklin’s current operations revolves around the distribution of Karl Storz products. This commercial relationship culminates with Karl Storz’s full acquisition of Anklin.
The team
Corporate and M&A partner Alex Enzler (pictured) led the MME team throughout the transaction, working alongside senior associate Martina Kim (corporate/M&A), partner Jonatan Baier (regulatory MedTech), partner Luca Hitz (competition), senior associate Simone Dubs (employment), as well as junior associate Marc Klingelfuss.
